PATENT CLAIM ANALYSIS

Application Number: 16066009
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "600000"]

Abstract:
[Problem] To provide a medicinal composition that is capable of improving the prognosis after the restart of the patient's own heartbeat even after the passage of a considerably long period of time after the restart of the patient's own heartbeat. [Solution] A gaseous medicinal composition for improving the prognosis alter the restart of the patients own heartbeat, said medicinal composition being to be administered to a human subject after the passage of at least 30 minutes after the restart of the patient's own heartbeat following cardiorespiratory arrest for at least 10 minutes. The medicinal composition according to the present invention, which contains hydrogen gas, is characterized in that a group of human patients administered with the medicinal composition shows improved prognosis after the restart of the patient's own heartbeat compared with another group of human patients not administered with the medicinal composition.

Claim (Index 8):
The method according to  claim 1 , wherein the pharmaceutical composition further comprises an inert gas.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 94.0
- Lexical Diversity: 2.32836
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12613919', '13020096', '13583283', '14889767', '12141864']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7186786141218104
- 35 USC 102 Novelty (BERT): 0.5076251419016704
- Combined Prediction Score: 0.6975732668997965
- Mean Citation Score: 166.105592
- Max Citation Score: 191.87282
- Similarity Product: 108.21287584897637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test